Actionable news
All posts from Actionable news
Actionable news in RLYP: RELYPSA Inc,

New data reinforce efficacy of Relypsa's Veltassa; shares up 5% premarket

Relypsa (NASDAQ:RLYP) is up 5% premarket on light volume in response to the announcement new data supporting the efficacy of hyperkalemia med Veltassa (patiromer) oral suspension. The results were presented at the 53rd Congress of the European Renal Association - European Dialysis and Transplant Association in Vienna, Austria.

Results from a Phase 1 study, RLY5016-101, in 32...